Literature DB >> 6681935

Events of reproductive life and the incidence of epithelial ovarian cancer.

H A Risch, N S Weiss, J L Lyon, J R Daling, J M Liff.   

Abstract

Women resident in six counties of Washington and Utah for whom diagnoses of epithelial ovarian cancer were made during 1975-1979 were interviewed concerning their menstrual, reproductive and medical histories. For comparison, interviews were also obtained from a random sample of women living in the same countries. Logistic regression methods were used, and histories of childbearing, miscarriages, lactation, and (in Washington) usage of oral contraceptives were found to be associated with decreased risk of ovarian cancer; the estimated relative risks were, respectively, 0.88 per pregnancy (i.e., 0.88(2) for two pregnancies, etc.) (p = 0.016), 0.82 per miscarriage (p = 0.049), 0.79 per year of lactation (p = 0.034), and 0.89 per year of oral contraception (p = 0.009). In addition, it was observed that the magnitudes of the diminished risks from these exposures substantially exceeded those which would have been expected solely on the basis of their inhibition of ovulation (X2(5) = 21.5, p = 0.0006). On the other hand, the lack of association found between the occurrence of ovarian cancer and either total dose or total time of exposure to noncontraceptive estrogens, or with a history of usage of thyroid medications, suggests that periods of reduced pituitary gonadotrophin secretion fail to reduce risk of ovarian cancer. Thus, although pregnancy, lactation and oral contraception appear to offer some protection against the development of epithelial ovarian cancer, the reasons remain obscure.

Entities:  

Keywords:  Abortion, Spontaneous; Americas; Biology; Body Weight; Cancer; Comparative Studies; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Family Planning; Fertility; Fertility Measurements; Gonadotropins; Gonadotropins, Pituitary; Incidence; Lactation; Maternal Physiology; Measurement; Neoplasms; North America; Northern America; Obesity; Oral Contraceptives; Ovarian Cancer; Parity; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Reproduction; Research Methodology; Studies; United States; Utah; Washington

Mesh:

Substances:

Year:  1983        PMID: 6681935     DOI: 10.1093/oxfordjournals.aje.a113523

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

Review 1.  Induced abortion as cancer risk factor: a review of epidemiological evidence.

Authors:  L I Remennick
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

Review 2.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

3.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

4.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 5.  Ovarian cancer in endometriosis: clinical and molecular aspects.

Authors:  B Lyttle; L Bernardi; M E Pavone
Journal:  Minerva Ginecol       Date:  2014-04

Review 6.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

7.  Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study.

Authors:  G Albrektsen; I Heuch; G Kvåle
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

8.  Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Authors:  Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb
Journal:  Eur J Epidemiol       Date:  2020-09-21       Impact factor: 8.082

9.  Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.

Authors:  Amy L Gross; Robert J Kurman; Russell Vang; Ie-Ming Shih; Kala Visvanathan
Journal:  J Oncol       Date:  2010-04-27       Impact factor: 4.375

10.  Lactation and cancer risk: is there a relation specific to breast cancer?

Authors:  G Kvåle; I Heuch
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.